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Xenopus postvitellogenic oocytes resume meiosis in vitro upon exposure to insulin or insulin-like growth factor 1 (IGF-1) via
a ras-dependent pathway, whereas stage IV (600 mm  diameter  1000 mm) oocytes cannot. The aim of the present study
was to determine which event(s) of the transduction pathway from IGF-1 receptor to maturation-promoting factor (MPF)
activation is de®cient in the small, vitellogenic, oocytes to explain their inability to undergo germinal vesicle breakdown (GVB)
after insulin treatment. We thus analyzed the effect of insulin on the Ras/Raf-dependent mitogen-activated protein kinase
cascade because of its crucial role prior to MPF activation. The effect of insulin on pp39mos synthesis in stage IV oocytes was
also studied since this protein kinase participates in the mitogen-activated protein kinase (MAPK) pathway as a MAPKK kinase
like Raf. Contrary to what is observed in postvitellogenic oocytes, MAPK was not activated in insulin-treated stage IV oocytes
even 20 hr after the stimulation. This was not caused by the absence of MAPK activators like MEK (MAPKK), Raf, or Ras, but
rather by the inability of insulin to activate Ras. Interestingly, injection of constitutively active raf mRNA as well as oncogenic
Ras protein, Ha-Ras lys12, in stage IV oocytes resulted in MAPK activation, whereas neither Mos accumulation nor GVB
occurred, suggesting that the Ras r Raf r MAPKK r MAPK cascade was functional but that MAPK activation alone was not
suf®cient for the mitogenic signal to proceed further down in the pathway leading to MPF activation. Treatment of stage IV
oocytes with insulin did not stimulate Mos synthesis either, indicating a dysfunction in the ``Mos synthesis machinery.'' The
present results show that incompetence of Xenopus stage IV oocytes to activate MPF in response to insulin is primarily due
to the inability of the peptide to activate Ras and to stimulate pp39mos synthesis and secondarily to a de®ciency in the mitogenic
pathway that connects MAPK to MPF activation. q 1997 Academic Press
INTRODUCTION meiosis resumption and progression to metaphase II,
wherein oocytes become arrested again until fertilization
Ovaries of Xenopus laevis adult females are populated (see Doree, 1990, for review). Treatments of postvitello-
with prophase-I-arrested oocytes at various stages of vitel- genic oocytes with progesterone or insulin/IGF-1 both lead
logenesis, from stage I to stage VI (Dumont, 1972) ac- to the activation of mitogen-activated protein kinase p42
cording to their size. Only late stage V and stage VI oocytes (MAPK; Haccard et al., 1990; Posada and Cooper, 1992;
(diameter ⁄1100 mm) can undergo maturation upon expo- Gotoh et al., 1995) and maturation-promoting factor
sure to progesterone or insulin/insulin-like growth factor (MPF), the latter being responsible for germinal vesicle
1 (IGF-1) (El-Etr et al., 1979; Masui and Clarke, 1979; breakdown (GVB), chromosome condensation, spindle for-
Maller and Koontz, 1981). This process is refered to as mation, and progression to metaphase II (see Doree, 1990,
and Nurse, 1990, for review). Progesterone- or insulin/IGF-
1-induced maturation also requires protein synthesis (Was-1 To whom correspondence should be addressed at UPRES-A
serman and Masui, 1995) and, in particular, the synthesis6026 CNRS, Biologie Cellulaire et Reproduction, UniversiteÂ de Re-
of pp39mos (Sagata et al., 1988; Daar et al., 1993), a serine/nnes 1, Bat. 13, Campus de Beaulieu, Avenue du GeÂneÂral Leclerc,
threonine protein kinase that is a product of the mos pro-35042 Rennes Cedex, France. Fax: 02.99.28.14.77. E-mail: Franck.
chesnel@univ-rennes1.fr. tooncogene but the function of which remains unclear dur-
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ing the early steps of oocyte maturation, i.e., before GVB. Since activation of the Raf-dependent MAP kinase cas-
cade, which lies right downstream of p21ras in theHowever, the early events of oocyte maturation partially
differ depending on the hormone used. Whereas progester- pathway leading to MPF activation, is required for oocyte
maturation (Muslin et al., 1993), particularly when it isone causes a rapid and transient decrease of the intraoocyte
cAMP level due to the inhibition of the adenylate cyclase triggered through a tyrosine kinase receptor pathway (Fa-
bian et al., 1993), experiments described in this study were(Sadler and Maller, 1981; Cicirelli and Smith, 1985), fol-
lowed by a decrease of the activity of PKA, a cAMP-depen- designed to test whether the incompetence of the stage IV
oocytes to resume meiosis in response to insulin was duedent protein kinase, insulin or IGF-1 stimulates a cAMP
phosphodiesterase (Sadler and Maller, 1989; Daar et al., to their inability to stimulate the Raf r MEK (MAP kinase
kinase) r MAPK pathway. In addition, microinjection of1991) after interacting with a type I IGF receptor in the
oocyte membrane (Hainaut et al., 1991; Janicot et al., 1991; oncogenic p21ras was performed in stage IV oocytes to
determine whether this oncogene was capable of activatingScavo et al., 1991). Furthermore, activation of p21ras, GAP
(GTPase-activating protein), and protein kinases C (PKC) the Raf r MEK r MAPK cascade. Finally, the capacity of
these meiotically incompetent oocytes to synthesizeare speci®c events associated with insulin- or IGF-1-in-
duced oocyte maturation. Indeed, microinjection of anti- pp39mos was investigated because of the major role of this
protooncogene during Xenopus oocyte maturation and be-bodies raised against p21ras blocked insulin- but not proges-
terone-induced GVB (Deshpande and Kung, 1987; Korn et cause it has been recently reported to be a MAPK kinase
kinase like Raf (Nebreda and Hunt, 1993; Posada et al.,al., 1987). A similar result was observed when using a syn-
thetic peptide or azatyrosine that both block GAP activa- 1993; Shibuya et al., 1993).
tion (Chung et al., 1991). The speci®c implication of PKC
in the insulin pathway leading to GVB seems to be im-
portant since neomycin, which binds to PI derivatives and MATERIALS AND METHODS
inhibits the production of DAG and IP3 from the hydroly-
sis of PIP2, inhibits insulin- or p21ras-induced maturation Oocytes
without affecting progesterone-induced maturation (Pan
Sexually mature Xenopus laevis females, at least 2 years old,
and Cooper, 1990). More precisely, the requirement of a were reared in the laboratory in water tanks (running tap water,
particular protein kinase C, namely, PKC z, activation in temperature, 18±207C). Ovary fragments were surgically removed
the insulin/p21ras pathway has been demonstrated (Domin- from animals anaesthetized with 0.2% ethylene glycol monophe-
guez et al., 1992). nyl ether (Merck) and placed in OR-2 medium (Wallace et al., 1973)
As observed with progesterone, acquisition of compe- containing (mM) 82.5 NaCl, 2.5 KCl, 1.0 CaCl2, 1.0 MgCl2, and
5.0 Hepes, pH 7.4. After rinsing in Ca2/-free OR-2 medium for 30tence to resume meiosis in response to insulin or IGF-1
min, ovarian pieces were treated for 30 min with type I collagenaseoccurs around the time Xenopus oocytes reach stage V of
(Sigma, 280 IU/ml in Ca2/-free OR-2) with gentle swirling. Com-vitellogenesis. Inability of growing, stage IV oocytes (600
plete removal of the follicular layers surrounding the oocytes wasmm  diameter  1000 mm) to undergo GVB after exposure
manually achieved, using ®ne forceps under a stereotaxic micro-to the peptides is not due to a lack of type I IGF receptors
scope. Only healthy oocytes were retained and allowed to equili-
or the presence of nonfunctional receptors since insulin is brate overnight at 167C in a suitable medium that allows insulin-
able to stimulate S6 phosphorylation and to induce an in- or IGF-1-induced maturation, i.e., a potassium-free medium de-
crease in intracellular pH (Stith and Maller, 1984). More- scribed by Maller and Koontz (1981) containing (mM) 83.0 NaCl,
over, p21ras, the activation of which is required speci®cally 0.5 CaCl2, 1.0 MgCl2, and 10.0 Hepes, pH 7.8, supplemented with
during insulin-induced maturation, as well as the associated 0.5 mg/ml polyvinylpyrrolidone (medium referred to as MK/PVP).
The next day, timing of maturation was studied on batches of 20GAP are already present in stage IV oocytes; treatment of
oocytes incubated in 2 ml MK/PVP at room temperature (19±227C)these oocytes with insulin causes an increase in membrane-
in the continuous presence of various inducers (detailed under Re-associated p21, similar to that observed in stage VI oocytes
sults). After stimulation, oocytes were observed at half-hour inter-(Davis and Sadler, 1992). Furthermore, stage IV oocytes al-
vals and scored as mature when a circular unpigmented area (whiteready contain all the molecules known to be closely in-
spot) appeared on the animal pole (Fortune, 1983). To assess the
volved in MPF activation; it includes preMPF, Cdc25 phos- disappearance of the germinal vesicle, the oocytes scored as mature
phatase (Rime et al., 1995) that activates MPF through the were boiled, cut in halves along the animal±vegetal axis, and ob-
dephosphorylation of threonine14 and tyrosine15 residues served under the stereomicroscope. Each set of experiments was
of its catalytic subunit, p34cdc2 (see Coleman and Dunphy, performed at least three times.
1994, for review), and also the protein kinase CAK (Brown
et al., 1994), which phosphorylates threonine 161 of p34cdc2
Plasmid Constructs and in Vitro RNA(see Clarke, 1995, for review), but MPF would be very
Transcriptionstrongly maintained in an inactive form (Rime et al., 1995).
Altogether, these data suggest that incompetence of small, The wild-type hraf-1/pSP64T and the truncated D-N*raf/pSP64T
stage IV oocytes to resume meiosis in response to insulin plasmids have been generously provided by D. Morrison and were
may be due to some de®ciencies in the ``mitogenic'' signal described elsewhere (Fabian et al., 1993). Both plasmid constructs
were linearized with EcoRI restriction enzyme and used as tem-transduction between p21ras and MPF activation.
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plates for transcription of 5*-capped RNAs using a mCAP mRNA fold diluted oocyte lysate (5 ml, i.e., 12.5 mg proteins; see previous
paragraph for extract preparation), the substrate, i.e., 2.6 mg/mlcapping kit (Stratagene, Heidelberg, Germany) as speci®ed by the
manufacturer. RNA pellets were resuspended in distilled water at histone H1 (Type III S, Sigma) or 2.5 mg/ml myelin basic protein
(MBP, Sigma), 20 mM protein kinase A inhibitor (PKI, Sigma), 400a ®nal concentration of 1.5 mg/ml and stored at 0707C until use.
mM cold ATP, and 50 mCi/ml [g-32P]ATP (4500 Ci/mmol, ICN Phar-
maceuticals). Reactions were terminated by adding 20 ml of 21Oocyte Microinjections
Laemmli sample buffer and heating to 1007C for 5 min. Phosphory-
Stage IV (900 mm  diameter  1000 mm) and stage VI (diameter lation status of both substrates was analyzed by 12.5% SDS±PAGE,
 1250 mm) oocytes were, respectively, microinjected in the cyto- the dried gels being autoradiographed for 12±48 hr at 0707C.
plasm with approximately 30 and 50 ng capped raf RNAs or 6 and To assay the kinase activity of Raf, it was ®rst necessary to
10 ng oncogenic Ha-Ras lys12, using a Nanoject variable automatic purify a Raf substrate: chinese hamster MEK-1 cDNA (Pages et al.,
injector (Drummond, Broomall, PA). Oncogenic Ha-Ras lys12 pro- 1994)Ðsubcloned in the EcoRI site of the GST gene fusion vector
tein, a generous gift of Drs. M. Pierre and B. Tocque, at a concentra- pGEX (Pharmacia Biotech, France)Ðwas a generous gift of Dr.
tion of 4 mg/ml was further diluted in microinjection buffer (20 mM Pouyssegur (UMR134/CNRS, University of Nice, France). The vec-
Hepes, pH 7.4, 0.2 mM EDTA, 0.1 M KCl, 20% glycerol). tor was transfected into competent bacteria Bl21 DE3, and after
Oocytes were incubated at 187C in MK/PVP for up to 24 hr. The IPTG induction, GST-MEK was puri®ed from bacterial lysate by
GVB rate was then scored and oocytes were homogenized in MPF af®nity chromatography on a glutathione Sepharose 4B column
buffer for Western blot analyses and in vitro kinase assays. (Pharmacia Biotech). The fractions of the eluate containing the
protein were pooled and dialyzed against 20 mM Hepes, pH 7.4,
20% glycerol, 0.2 mM EDTA, 0.1 M KCl, 1 mM DTT, and proteaseWestern Blot Analysis
inhibitors (Sigma): 2 mM PMSF, 1 mg/ml leupeptin, and 10 mg/ml
Crude oocyte lysates were usually prepared by homogenizing 8 aprotinin. Dialysates were aliquoted and stored at0707C. The assay
to 13 oocytes (depending upon the vitellogenic stage considered) of Raf kinase activity was performed under the same conditions as
in 40 ml MPF buffer (Cyert and Kirschner, 1988): 80 mM b-glycero- those used for MAPK or H1K assays after replacing H1 or MBP by
phosphate, 20 mM EGTA, 15 mM MgCl2, 1 mM dithiothreitol, 20 2.5 ml GST-MEK dialysate.
mM Hepes, pH 7.5, containing 0.2 mM PMSF, 0.5 mg/ml leupeptin,
and 1 mM sodium orthovanadate. Lysates were centrifugated at
15,000g for 15 min at 47C and the supernatants, which contained
5 mg/ml oocyte proteins, were stored at 0707C until use. One vol- RESULTS
ume of double-strength Laemmli sample buffer (Laemmli, 1970)
was added to 1 vol of supernatant. Oocyte proteins were denatured Insulin Does Not Induce MAPK Activation
by heating the mixture to 1007C for 5 min and then separated by in Stage IV Oocytes7.5 or 12.5% SDS±polyacrylamide gel electrophoresis (SDS±PAGE,
prepared from an acrylamide:bisacrylamide stock solution of We ®rst con®rmed that Xenopus 42-kDa MAPK was acti-
30%:0.8%, respectively). In the particular case of MAP kinase im- vated in insulin-induced stage VI oocytes around the time
munodetection, proteins were resolved by 15% SDS±PAGE (pre- they started to undergo GVB. Indeed, from 10 hr after insu-
pared from an acrylamide:bisacrylamide stock solution of
lin addition, MAPK mobility on a 15% SDS±polyacryl-30%:0.18%, respectively) in order to increase the separation of the
amide gel was largely retarded in postvitellogenic oocytedifferent MAPK phosphorylated forms. Proteins were transferred
extracts (Fig. 1A), re¯ecting an activating phosphorylationonto nitrocellulose membranes (pore size, 0.45 mm; Amersham, Les
of the protein. This mobility shift coincided with a dramaticUlis, France) using a semidry blotting apparatus (Bioblock Scien-
ti®c, Strasbourg, France). Membranes were blocked with 5% increase of MBP kinase activity in the same oocyte lysates
skimmed milk in 10 mM PBS, pH 7.4, containing 0.1% Tween 20 (Fig. 1B) which was sustained up to 20 hr after insulin treat-
(PBS-T) and incubated overnight at 57C with the primary antibodies ment. In contrast, when stage IV oocytes (900 mm  diame-
diluted in the blocking solution. Raf-1, MAPK p42, and Mos were ter  1000 mm) were treated under the same conditions,
detected using rabbit af®nity-puri®ed polyclonal antibodies (San- i.e., with 5 mM insulin for 20 hr, they did not undergo GVB,
taCruz Biotechnology, Heidelberg, Germany) respectively directed and neither a shift of MAPK mobility (Fig. 1A) nor an in-
against a peptide corresponding to the 20 carboxyterminal amino
crease of MBP kinase activity (Fig. 1B) was observed in theacids of human Raf-1 (C-20), to 14 amino acids mapping within
lysates. Since no change of both parameters was detectedthe carboxy terminus of rat ERK2 (C-14), and to 12 amino acids
even 20 hr after the stimulation, it could be concluded frommapping within the carboxy terminus of Xenopus Mos (C237).
these ®rst results that insulin-induced MAP kinase activa-Membranes were washed ®ve times with the blocking solution and
then incubated at room temperature for 2 hr with a horseradish tion is not delayed but is prevented in these vitellogenic
peroxidase-coupled secondary antibody (Sigma) diluted in the oocytes. It should be noted that under our experimental
blocking solution. After ®ve washes in PBS-T, membranes were conditions (lower bisacrylamide content in the gels to allow
processed using the ECL detection system (Amersham). Data from a better separation of MAPK phosphorylated forms), MAPK
Western blots were quanti®ed using the densitometer ScanJet IIC in control oocyte lysates was unexpectedly recognized by
(Hewlett±Packard). anti-MAPK antibodies as a doublet instead of a single band.
Since only the upper band shifted to a slower migrating form
In Vitro Protein Kinase Assays when oocytes started to undergo GVB, it was considered the
inactive form of MAPK. The nature of the lower band ofH1 as well as MAP kinase reactions were performed at 307C for
30 min in a total volume of 20 ml MPF buffer containing the two- the doublet remains obscure.
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should also consider the possibility that Raf, which indi-
rectly stimulates MAPK activity via MEK is either absent or
cannot be activated by insulin in meiotically incompetent
oocytes.
Insulin Does Not Induce Raf Activation
in Stage IV Oocytes
It was dif®cult to quantify the Raf-1 amount in oocytes
during vitellogenesis in the same way we did the MEK and
MAPK measurements. Immunoblots performed with anti-
Raf-1 antibodies displayed bands with weaker intensity
(even when prolonging the autoradiography up to 10 min)
that were thereafter very dif®cult to analyze densitomet-
rically. Nevertheless, Raf-1 was already detectable in con-
trol stage IV oocytes as a doublet with an apparent molecu-
lar weight of 68 kDa (Fig. 3A). Its accumulation reached
roughly 50±70% of the Raf content in stage VI oocytes.
In insulin-treated stage VI oocytes, Raf shifted to a slower
migrating band around the time the oocytes started to un-
dergo GVB, i.e., by 6 hr after addition of the peptide in
the experiment displayed in Fig. 3A. At that time, the Raf
amount in the oocytes increased too, which con®rmed pre-
vious observation made during progesterone-induced oo-
cyte maturation (Muslin et al., 1993). Neither an increaseFIG. 1. Comparison of p42 MAPK activity in stage IV versus stage
of Raf amount nor a shift were observed in stage IV oocytesVI oocytes upon exposure to insulin. Oocytes at both stages of
treated under the same conditions, suggesting that insulindevelopment were incubated in MK/PVP in presence of 5 mM insu-
could not activate Raf in these small oocytes. However,lin for 20 hr and oocytes (13, stage IV, or 8, stage VI) were lysed in
80 ml MPF buffer every 2 hr, beginning from 8 hr after addition of contrary to MAPK, the mobility shift of Raf is not always
insulin. The same oocytes lysates were then probed with an anti- considered to be a reliable marker of its activation.
ERK2 antibody used at a 1/1000 dilution (A) or analyzed in a MBP To con®rm these results, it was therefore necessary to
kinase assay (B) as described under Materials and Methods. The measure Raf protein kinase activity in oocyte extracts at
percentages of stage VI oocytes that have undergone GVB are indi- various times after insulin addition in both stage IV and VI
cated below panel B (no GVB was observed in stage IV oocytes at oocytes by performing an in vitro kinase assay. For this
any time during the experiment). These results are representative
purpose, we ®rst puri®ed Raf substrate, MEK-1, as describedof at least three independent experiments.
under Materials and Methods. Instead of an expected 75-
kDa protein, a mixture of four major polypeptides with mo-
lecular weights of 60, 38, 33, and 31 kDa were eluted out
of the glutathione Sepharose 4B column and were quantita-The incapacity of insulin to activate MAPK in small oo-
cytes could be simply explained by a lack of or an insuf®- tively represented in the following order: p33 @ p38  p31
 p60. They were all recognized by an anti-MEK antibody,cient level of MAPK activators. To test this hypothesis, we
estimated the content of MEK, the direct upstream activator suggesting they likely were MEK degradation products. In
preliminary experiments of in vitro kinase assays, p31, p33,of MAPK, as well as MAPK itself, in oocytes from stage III
to stage VI of vitellogenesis. As shown in Fig. 2, MEK and and p38, but not p60, were phosphorylated by (i) crude ex-
tracts of stage VI oocytes that had undergone progesterone-MAPK were already present in stage III oocytes and slowly
accumulated up to stage V, but their amount dramatically induced GVB and that were reported to contain activated
raf (Fabian et al., 1993; Muslin et al., 1993) and (ii) crudeincreased at the very end of vitellogenesis, i.e., between
stages V and VI, which corresponds to the time oocytes extracts of oocytes microinjected with the constitutively
active form of Raf but not by crude extracts of control ``GV''become competent to resume meiosis. Thus, the amounts
of MEK and MAPK in stage IV oocytes represented, respec- oocytes (data not shown), suggesting that these three pro-
teins could be used as potential Raf substrates. The resultstively, 30 and 59% of what was found in postvitellogenic
oocytes. These increases were not related to the increased of a typical in vitro MEK kinase assay displayed in Fig. 3B
showed that p33, p31, and p38 (to a lesser extent) weresize of the oocytes per se because equal amounts of oocyte
proteins were loaded in each lane rather than an equal num- strongly phosphorylated by lysates of stage VI oocytes by
the time they started to undergo GVB in response to insulin,ber of oocytes. The low level of MEK protein in particular
may, therefore, be a limiting factor in the transduction of whereas none of them were phosphorylated by lysates of
stage IV oocytes within the ®rst 12 hr of insulin treatment.insulin mitogenic signal in stage IV oocytes. However, we
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FIG. 2. Accumulation of MAPK and MAPKK (MEK) at various stages of Xenopus oocyte development. 20 mg of proteins (vitellus excluded)
of stage III, IV, V, and VI oocytes was resolved by 12.5% SDS±PAGE, transferred onto nitrocellulose membranes, and probed either with
an anti-ERK2 antibody used at a 1:1,000 dilution to detect p42 MAPK or with an anti-MEK antibody used at a 1:500 dilution. Results of
typical Western blots are displayed above the histograms. The relative amounts of MAPK and MEK were evaluated by densitometry of
the autoradiographs and expressed as percentages of the intensity of the band observed in stage VI oocytes, where both MAPK and MEK
contents were shown as being the highest. Each bar represents the mean { SEM of six (MAPK) or three (MEK) independent experiments.
There was therefore a good correlation between the results and VI oocytes. The results ®rst con®rmed previous ®ndings
(Fabian et al., 1993; Muslin et al., 1993): D-N*Raf RNAof these in vitro kinase assays (Fig. 3B) and the immunoblots
of the Fig. 3A. These results strengthen the fact that insulin injection into stage VI oocytes led within 24 hr to 32±75%
GVB (Table 1), MPF, and MAPK activation (Figs. 4A anddoes not activate Raf in stage IV oocytes even though we
have not been able to immunoprecipitate an active form of 4B, respectively), while oocytes injected with the same
amount of RNA encoding the wild-type form of Raf re-Raf in the oocyte lysates, after using two different antibod-
ies, to prove that this kinase was responsable in our extracts mained in the GV stage and thus behaved as control nonin-
jected oocytes, except for 2 of 190 (Table 1, Expt. 1) thatfor the phosphorylation of p31, p33, and p38.
likely did undergo spontaneous GVB.
In contrast, a large majority, if not all, of stage IV oocytes
Microinjection of D-N*Raf RNA into Stage IV did not undergo GVB within 24 hr after microinjection of
Oocytes Does Not Trigger GVB but Does Induce
D-N*Raf RNA (Table 1). However, in every experiment us-
MAPK Activation ing these small oocytes, D-N*Raf stimulated MAP kinase
activity as illustrated by the increase of MBP kinase activityWe then asked whether stage IV oocytes would be able to
undergo GVB if Raf was activated. To address this question, (Fig. 4B) as well as the typical retarded mobility of the mole-
cule on a 15% polyacrylamide gel (Fig. 4C). These resultscapped D-N*Raf RNA coding for a truncated form of Raf
that lacks the regulatory domain and therefore is expressed indicated that (i) the low content of MEK in stage IV oocytes
was not a limiting factor in mediating Raf-induced MAPKas a constitutively active kinase was injected into stage IV
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Neither Constitutively Active Raf (D-N*Raf)
nor Insulin Stimulate pp39mos Synthesis
in Stage IV Oocytes
Since it has been recently hypothesized that MAPK may
stimulate pp39mos synthesis (Matten et al., 1996; Roy et al.,
1996) during oocyte maturation, lysates of stage IV/stage VI
oocytes microinjected either with wtRaf or D-N*Raf RNA
were probed with an anti-Mos antibody. D-N*Raf stimu-
lated Mos accumulation only in stage VI oocytes (Figs. 5A
and 5B), especially in those that had undergone GVB. In a
second experiment, oocyte extracts were made 6, 12, and
24 hr after microinjection to determine which of MAPK or
Mos synthesis was stimulated ®rst. As illustrated in Fig.
5B, MAPK started to shift at 6 hr postinjection and was
totally under the active form by 12 hr, whereas Mos was
barely detectable, its accumulation dramatically increasing
between 12 and 24 hr. These results showed that MAPK
activation preceded Mos accumulation. Finally, we com-
pared Mos accumulation in stage IV versus stage VI oocytes
after stimulation by 5 mM insulin. Mos became detectable
in postvitellogenic oocytes as soon as 2 hr after insulin
stimulation and its accumulation peaked by the time (8 hr)
62.5% of the oocytes had undergone GVB (Fig. 6), which
con®rmed previous observations (Roy et al., 1996) about
Mos synthesis during progesterone-induced maturation. In
contrast, Mos could not be detected in insulin-treated stage
IV oocytes within 12 hr of exposure, which reinforced the
fact that stage IV oocytes are not able to synthesize pp39mos.
In view of these last results, we could not exclude that
phosphorylation of MEK polypeptides p31, p33, and p38 by
crude extracts of insulin-treated postvitellogenic oocytes
FIG. 3. Comparison of Raf activity in stage IV versus stage VI (Fig. 3B) was due to Mos rather than Raf since both MEK
oocytes upon exposure to insulin. Oocytes at both stages of devel- kinases appear to be activated around the same time in
opment were incubated in MK/PVP in presence of 5 mM insulin
for 12 hr and oocytes (13, stage IV, or 8, stage VI) were lysed in 40
ml MPF buffer every 2 hr. Oocyte lysates were then probed with an
anti-Raf-1 antibody used at a 1:200 dilution (A) or analyzed in a
TABLE 1MEK kinase assay using MEK p31, p33, and p38 as substrates (B)
as described under Materials and Methods. The percentages of stage Comparison of the GVB Rates in Stage IV versus Stage VI
VI oocytes that have undergone GVB are indicated below both pan- Oocytes after Microinjection of D-N*Raf RNA
els (no GVB was observed in stage IV oocytes at any time during
Number of GVB oocytesa numberthe experiment). These results are representative of at least three
of injected oocytesindependent experiments. Molecular masses (in kilodaltons) are
indicated to the right of B. n.d., not determined.
wt Raf RNAb D-N*Raf RNAb
Stage IV Stage VI Stage IV Stage VI
activation and (ii) that MAPK activation alone was not suf- Experiment 1 0/40 2/40 (5%)c 4/50 (8%) 16/50 (32.0%)
®cient to activate MPF and trigger GVB. Only four oocytes, Experiment 2 0/40 0/40 0/70 22/48 (45.8%)
Experiment 3 0/30 0/60 0/40 27/36 (75.0%)studied in Expt. 1 (Table 1), displayed a white spot on their
Experiment 4 0/39 0/50 0/48 35/49 (71.4%)animal pole and therefore were scored as GVB oocytes. They
were lysed to be used in Western blots and kinase assays a The number of oocytes that had undergone GVB was scored 24and thus could not be ®xed to assess disappearance of the
hr after microinjection.
GV. Since no H1 kinase activity was detected in the lysate b Stage IV (900 mm diameter 1000 mm) and stage VI (diameter
containing these four oocytes (data not shown), it was con-  1250 mm) denuded oocytes were, respectively, microinjected into
cluded that they had been misscored and that the white the cytoplasm with approximately 30 and 50 ng of either wt (used
spot likely corresponded to the intact germinal vesicle that as control) or D-N*Raf capped RNA diluted in water.
c x%, the percentage of GVB.had migrated up near the oocyte membrane.
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Microinjection of Ha-Ras lys12 Protein into Stage
IV Oocytes neither Triggers GVB nor Mos
Synthesis but Does Induce Raf and MAPK
Activation
In order to be activated, Raf must be translocated ®rst to
the oocyte membrane by activated Ras-GTP, where it is
then phosphorylated by Raf-activating factor(s), the nature
of which remains to be elucidated. The simplest explana-
tions for the inability of insulin to stimulate Raf activity
and subsequent MAPK cascade in stage IV oocytes are that
activated Ras does not properly target Raf to the membrane
FIG. 4. Effect of D-N*Raf RNA injection in stage IV and stage VI
oocytes on H1 kinase and MAP kinase activities. Stage IV and VI
oocytes were microinjected, respectively, with 30 and 50 ng D-
N*Raf RNA (DN*) or wild-type Raf RNA (wt) as control RNA. After
a 24-hr incubation in MK/PVP, GVB was scored and oocytes (13,
stage IV, or 8, stage VI) were lysed in 40 ml MPF buffer; in the group
of stage VI oocytes injected with D-N*Raf RNA, only those that
had undergone GVB were lysed. A group of noninjected oocytes
(n.i.) was also used as control. The same oocytes lysates were either
analyzed in a H1 kinase (A) or a MBP kinase assay (B) or probed
with an anti-ERK2 antibody used at a 1:1000 dilution (C) as de-
scribed under Materials and Methods. These results are representa-
tive of at least three independent experiments.
these oocytes. To test this hypothesis, the same kinase
assay was performed with crude extracts of stage IV and
VI oocytes previously injected with D-N*Raf mRNA since,
contrary to stage VI oocytes, no Mos protein could be de-
tected in stage IV oocytes. Figure 7 shows that only p31
was phosphorylated by stage IV oocyte extracts as soon as
FIG. 5. Effect of D-N*Raf RNA injection in stage IV and/or stage6 hr (vs 12 hr in stage VI oocytes) after microinjection, while
VI oocytes on pp39mos accumulation and MAPK activity. (A) Stagep33 and p38 were only phosphorylated in extracts of stage
IV and VI oocytes were microinjected, respectively, with 30 and 50
VI oocytes from 24 hr after microinjection, i.e., when Mos ng D-N*Raf or wild-type Raf RNA as control RNA. After a 24-hr
dramatically accumulated (Fig. 5B). In addition, microinjec- incubation in MK/PVP, GVB was scored and oocytes (13, stage IV,
tion in stage VI oocytes of Raslys12, which is known to or 8, stage VI) were lysed in 40 ml MPF buffer; in the group of stage
VI oocytes injected with D-N*Raf RNA, oocytes that had undergonequickly activate Raf in several cell types, led to similar
GVB were homogenized separately from those that had not, n.i.,results, i.e., phosphorylation of p31 ®rst, followed by that
non-injected oocytes. (B) Stage VI oocytes were microinjected withof p33 and p38 by the time Mos was neosynthesized (data
50 ng of either D-N*Raf or wild-type Raf RNA (wt). 8 oocytes werenot shown). These data strongly suggest that in our in vitro
lysed before (0) or 6, 12, and 24 hr following microinjection. In bothkinase assay shown in Fig. 3B, phosphorylation of MEK p31
series (A and B), the oocytes lysates were probed with an anti-Mosxe
accounts for Raf activation, whereas that of p33 and p38 antibody used at a 1:500 dilution or with an anti-ERK2 antibody,
account for Mos activation, unless a third MEK kinase is to detect p42 MAPK, used at a 1:1000 dilution, as described under
activated in insulin-treated oocytes. Such a kinase has not Materials and Methods. These results are representative of at least
three independent experiments.yet been characterized in Xenopus oocytes.
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Rime et al., 1995) and probably downstream of the p21ras
system (Davis and Sadler, 1992) when insulin is used to
induce maturation. Like MPF, MAPK is a protein kinase
which plays a central role during oocyte maturation in ver-
tebrates. However, in Xenopus, a controversy has long re-
mained about which of MAPK or MPF was activated ®rst
in the cascade of events leading to GVB. It is now well
understood that MAPK activation, which is undoubtedly
necessary for the progression from meiosis I to meiosis II
and for metaphase II arrest (Haccard et al., 1993), is also
required prior GVB to activate MPF (see Gotoh and Nishida,
1995, for review). In view of these data, we investigated
whether a dysfunction of the MAPK pathway could be the
source of the meiotic incompetence of stage IV oocytes. TheFIG. 6. Time course of pp39mos accumulation in stage IV and VI
present results indeed show that although the Ras r Raf roocytes upon exposure to insulin. Oocytes at both stages of devel-
opment were incubated in MK/PVP in presence of 5 mM insulin MEK r MAPK pathway is functional in stage IV oocytes,
for 12 hr and oocytes (13, stage IV; or 8, stage VI) were lysed in 40 insulin cannot stimulate MAPK activity in these small oo-
ml MPF buffer every 2 hr. Oocyte lysates were then probed with cytes, likely because Ras cannot be properly activated and
an anti-Mosxe antibody used at a dilution of 1/500 as described also because they are not able to synthesize pp39mos. Indeed,
under Materials and Methods. The percentages of stage VI oocytes whereas insulin, Raf, or Ras stimulate pp39mos in stage VI
that have undergone GVB are indicated (no GVB was observed in
oocytes, none of these inducers is capable of stimulatingstage IV oocytes at any time during the experiment). These results
Mos synthesis in stage IV oocytes.are representative of at least three independent experiments.
The fact that constitutively active Raf could activate
MAPK in stage IV oocytes whereas insulin could not, com-
bined with observations of Davis and Sadler (1992) demon-
strating that p21ras system was present in stage IV oocytesand/or Raf stimulators are not present. To verify this hy-
and was recruited to the oocyte membrane after insulinpothesis, we injected oncogenic Ras, Ha-Ras lys12, both in
treatment, ®rst led us to postulate that the inability of insu-stage IV and stage VI oocytes and assayed Raf, MAP kinase,
lin to stimulate the MAPK pathway was due to an interrup-and H1 kinase activities as well as Mos accumulation (Fig.
tion of the transduction pathway between Ras and Raf.8). Contrary to stage VI oocytes, none of the stage IV oocytes
However, this hypothesis is invalidated by our present re-resumed meiosis upon microinjection of Ha-Ras lys12, even
sults showing that microinjection of oncogenic Ras in stage24 hr after the injection. This was ascertained by the ab-
IV oocytes elicited a stimulation of both Raf and MAPK assence of GVB and H1 kinase activation, which con®rmed
quickly as in stage VI oocytes (Fig. 8); rather, it indicatesprevious results by Johnson et al. (1990). However, MAP
that insulin cannot activate Ras in stage IV oocytes. RasKinase was activated in a similar fashion in both types of
activation is a complex mechanism which requires the con-oocytes as soon as 6 hr after Ha-Ras lys12 microinjection
version from the GDP-bound (inactive) to the GTP-bound(Fig. 8B). Moreover, in the MEK kinase assay, MEK p31
was phosphorylated in stage IV oocytes with a similar time
course but sometimes with a smaller amplitude than in
stage VI oocytes (Fig. 8A), strongly suggesting that onco-
genic Ras activates Raf-dependent MAP kinase cascade in
stage IV as in stage VI oocytes. Finally, as shown after mi-
croinjecting Raf RNA (Figs. 5A and 7), a correlation between
MEK p33 and p38 in vitro phosphorylation and pp39Mos
accumulation (Fig. 8D) was again observed in Ras-microin-
jected stage VI oocytes, whereas none of these two polypep-
tides were phosphorylated by injected stage IV oocyte ex-
tracts, in which no Mos protein could be detected within
24 hr after microinjection.
FIG. 7. Comparison of MEK kinase activities in stage IV versus
stage VI oocytes following D-N*Raf RNA injection. Stage IV and
VI oocytes were microinjected respectively with 30 and 50 ng D-DISCUSSION
N*Raf RNA. 13 stage IV or 8 stage VI oocytes were lysed in 80 ml
MPF buffer before (0) or 6, 12, and 24 hr following microinjection.
Incompetence of Xenopus stage IV oocytes to resume mei- MEK kinase activity was measured in crude extracts using MEK
osis has been so far explained by a dysfunction of event(s) p31, p33, and p38 as substrates, as described under Materials and
Methods and in the legend to Fig. 3B.acting prior to MPF activation (Sadler and Maller, 1983;
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Indeed, the fact that both constitutively active Raf, ex-
pressed after microinjection of D-N*Raf RNA, and onco-
genic Ha-Ras lys12 did not trigger GVB in stage IV oocytes
although MAPK was activated as well as in Ras- or Raf-
injected fully grown oocytes clearly indicates that MAPK
activation, if necessary, is not suf®cient for these small
oocytes to undergo GVB. At ®rst sight, the inef®ciency of
Ras and Raf to induce GVB in stage IV oocytes could be
explained by the absence of Mos accumulation following
MAPK activation, whereas such accumulation was ob-
served in Ras- or Raf-injected postvitellogenic oocytes prior
GVB. However, two reports ®rst showed that Raf-induced
GVB did not require Mos synthesis since coinjection of mos
antisense oligonucleotide did not prevent Raf-injected stage
VI oocytes from undergoing GVB (Fabian et al., 1993; Mus-
lin et al., 1993). Moreover, GVB induced after microinjec-
tion in stage VI oocytes of Ha-Ras lys12 could still be ob-
served when these oocytes were incubated in presence of
cycloheximide at a concentration (2 mg/ml) which blocks
protein synthesis (Allende et al., 1988; Nebreda et al., 1993;
our unpublished observations). Therefore, the inability of
Ras and Raf to induce GVB in stage IV oocytes may rather
be due to the dysfunction of a still unknown mechanism(s)
that directly connects MAPK to preMPF r MPF conversion.
FIG. 8. Effect of oncogenic Ras injection in stage IV and stage VI Finally, we cannot rule out the possibility that a MAPK-
oocytes on MEK kinase (A), MAP kinase (B), H1 kinase activities independent pathway is involved during Raf-induced GVB
(C), and Mos accumulation (D). Stage IV and VI oocytes were mi- in postvitellogenic oocytes. Indeed, Galaktionov et al.
croinjected, respectively, with 6 and 10 ng Ha-Ras lys12 protein (1995) demonstrated that Raf associates with, phosphory-
and further incubated in MK/PVP. Besides scoring GVB, 13 stage lates, and activates Cdc25 phosphatase. But even if this
IV and 8 stage VI oocytes were then lysed in 40 ml MPF buffer pathway was functional in stage IV oocytes, it would not
before (0) or 6, 12, and 24 hr following microinjection. MEK kinase,
lead to GVB since injection of Cdc25 phosphatase into theseMAPK, and MPF activities were measured in twofold diluted ex-
small oocytes neither stimulates MPF nor triggers GVB,tracts by using, respectively, MEK p31/p33/p38, MBP, and histone
contrary to what is observed in stage VI oocytes (Rime etH1 as substrates, as previously described. Crude oocyte lysates were
al., 1995). Altogether, these data suggest that the failure ofalso probed with an anti-Mosxe antibody used at a dilution of 1/
500 as described under Materials and Methods. These results are insulin to stimulate Raf via Ras blocks the transduction
representative of three independent experiments. of the mitogenic signal into several parallel pathways that
include MAPK, Mos, and Cdc25, the combined activation
of which may likely lead to GVB (Fig. 9).
Mos accumulation, which peaks in Xenopus stage VI oo-
cytes around the time they undergo GVB in response either(active) form. Two major proteins seem so far to participate
in the activation of Ras: the GTP/GDP exchange protein Sos to progesterone (Sagata et al., 1989; Roy et al., 1996) or
insulin (our present results, Fig. 6) and which is requiredand the 120-kDa protein GAP (Baltensperger et al., 1993). As
stage IV and stage VI oocytes display comparable levels of during progesterone- as well as insulin-induced meiotic
maturation in Xenopus oocytes (Sagata et al., 1988; BarrettGAP activity (Davis and Sadler, 1992), the inability of insu-
lin to activate Ras in stage IV oocytes may be caused by a et al., 1990), has been reported to be directly and positively
regulated by MAPK (Matten et al., 1996; Roy et al., 1996)dysfunction in the cascade of events linking IGF-1R to Sos,
which involves docking proteins like Shc and IRS-1 and via a yet unknown mechanism. We con®rmed this role of
MAPK when showing that constitutively active Raf ex-the adaptor molecule Grb2 (see Grigorescu et al., 1994, for
review). Effects of insulin on Ras GTP loading and on re- pressed in postvitellogenic oocytes did induce Mos accumu-
lation a few hours after stimulating MAPK and that thecruitment of Sos in the membrane of stage IV versus stage
VI oocytes are currently being investigated in our laboratory dramatic increase of Mos content in insulin-treated oocytes
coincided with MAPK activation. From our results, it can-to better understand how these upstream elements of the
insulin signaling pathway take place during acquisition of not be excluded that Mos accumulation results from
MAPK-induced MPF activation instead of being directlymeiotic competence.
Nevertheless, the absence of Raf-dependent MAPK acti- stimulated by MAPK (Fig. 9). However, since Mos started
to be detected in postvitellogenic oocytes as soon as 2 hrvation in stage IV oocytes exposed to insulin cannot alone
account for the inability of the hormone to trigger GVB. after hormone addition, i.e., at a time MAPK was not yet
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FIG. 9. Tentative model to explain why Xenopus stage IV oocytes are incompetent to undergo GVB in response to insulin. This scheme
illustrates the main signaling pathways turned on by insulin in stage VI oocytes to activate MPF and trigger GVB (broken arrows indicate
pathways wherein intermediate steps have not been precisely de®ned). In stage IV oocytes, in addition to the fact that Cdc25 cannot
activate MPF (Rime et al., 1995), it appears that the Ras/Raf/MEK/MAPK pathway is functional but (i) Ras cannot be activated, (ii) Mos
synthesis cannot be stimulated, and (iii) an active MAPK cannot induce MPF activation.
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